Phase II study of epirubicin, oxaliplatin and docetaxel combination in metastatic gastric or gastroesophageal junction adenocarcinoma

Luigi Di Lauro, Laura Giacinti, Maria Grazia Arena, Domenico Sergi, Silvia Ileana Fattoruso, Diana Giannarelli, Massimo Lopez

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Phase II study of epirubicin, oxaliplatin and docetaxel combination in metastatic gastric or gastroesophageal junction adenocarcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences